Option Care Health (NASDAQ: OPCH) reported Q2 EPS of ($0.04), $0.07 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $740.8 million versus the consensus estimate of $690.95 million.

Full Year 2020 Guidance

For the full year, the Company expects to generate between $200 million and $210 million in Adjusted EBITDA and at least $50 million in free cash flow, defined by the Company as net change in ending cash balance compared to the cash balance at December 31, 2019.

For earnings history and earnings-related data on Option Care Health (OPCH) click here.